The Cathay YSS Distributors Co., Inc.
A filipino pharmaceutical company establised over 3 decades
A Filipino national pharmaceutical company established in late 1992. Its core business is the marketing, promotion, and distribution of human healthcare products, with a primary focus on providing high-quality yet affordable medicines to the Filipino market. They specialize in therapeutic areas like Cardiovascular, Diabetes & Metabolism, Pulmonology & Allergy, Nephrology and Neurological conditions. Cathay YSS is a trusted drug trader and distributor committed to making essential and technologically advanced pharmaceutical products accessible and affordable.
Our Foundation
Vision of Our Founder
Mr. Yao Shiong Shio
This profound sense of purpose extended beyond merely providing products; it encompassed a deep commitment to the community. Influenced by his lifelong dedication to public service, the founder envisioned Cathay YSS as an active contributor to the health of the Filipino nation, not just a supplier of medicines. This meant fostering strong relationships built on integrity and trust with both local and international partners. For YSS, this enterprise was about building a legacy of care and reliability that would positively impact the country for generations.
Ultimately, the founder’s vision was a powerful blend of business acumen and human- centered values. He believed that a company’s success should be measured not only by its profitability but also by its positive contribution to society. This philosophy inspired a company culture dedicated to excellence and driven by a higher purpose, where the development of its own people was as critical as the products they distributed. His legacy ensures that Cathay YSS remains dedicated to providing affordable, quality healthcare and continues to be a trusted partner in building a healthier, more prosperous Philippines.
- Love
- Innovation
- Quality
- Integrity
A look at the milestones that shaped who we are today
Our Journey Through the Years
Cathay YSS Distributors Co., Inc. (CYDC) was founded with a clear mission to make high-quality pharmaceutical products accessible and affordable to Filipino families.
CYDC began operations in the Philippines, partnering with Biolab (Thailand), Bonomelli (Italy), and Laphal (France) as its first international principals.
CYDC strengthened its portfolio by partnering with YSS Laboratories (Philippines) and Aldo-Union Spa (Spain), expanding its commitment to patient care.
The company launched its first flagship product, Lipway SR (fenofibrate), marking a milestone in brand development.
CYDC reorganized its product lines into two specialized groups, forming an Internal Medicine (IM) team and a Pedia team.
The IM product lines split into dedicated Cardio and Metabolic teams to better address therapeutic needs.
The Cardio team’s portfolio grew with the addition of nephrology products.
The Metabolic team expanded further by incorporating Pulmo and CNS products.
CYDC created a specialized CNS/Nephro team to concentrate expertise and resources in those areas.
Established as one of the fastest-growing pharmaceutical companies in the Philippines with over 50 trusted brands, CYDC continues to serve healthcare professionals and patients nationwide with unwavering dedication.
What Drives Us
Mission, Vision & Values
Corporate Mission
We aspire to be the foremost Filipino Pharmaceutical Company delivering quality service to our customers and contributing effectively to the health care of the country.
Corporate Vision
We commit ourselves to service excellence in the promotion and delivering of essential, as well as technologically advanced, medical products. We aim to bring health care within the average workman’s reach. We value the total human development of our people and shall uphold integrity in the conduct of our business. Thus, we can meaningfully contribute to the nation-building.
Corporate Values
Driven by our Love of God, we demonstrate unwavering commitment and loyalty in every endeavor. We operate with integrity to earn trust, which fuels our sustained profitability and collective success.